IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Nano-Delivery for CRISPR-Cas9 Technology in Precision Medicine

Nano-Delivery for CRISPR-Cas9 Technology in Precision Medicine
View Sample PDF
Author(s): Suresh Waghamare (NIMS Institute of Pharmacy, NIMS University, Jaipur, India), Deepak Uttamrao Bhusare (Digambarrao Bindu ACS College, India), Annasaheb Kudhekar (Nandkumar Shinde College of Pharmacy, India), Jahed Sayyad (NIMS Institute of Pharmacy, NIMS University, Jaipur, India), Amol Darwade (S.N.D. College of Pharmacy, India), Poonam Kodag (Rashtriya College of Pharmacy, India), Pooja Paulbudhe (Oyster Institute of Pharmacy, India)and Vikas Ashok Deshmane (Oyster Institute of Pharmacy, India)
Copyright: 2026
Pages: 32
Source title: CRISPR-Cas9 Technology for Precision Medicine
Source Author(s)/Editor(s): Jen-Tsung Chen (National University of Kaohsiung, Taiwan)
DOI: 10.4018/979-8-3373-4857-5.ch011

Purchase

View Nano-Delivery for CRISPR-Cas9 Technology in Precision Medicine on the publisher's website for pricing and purchasing information.

Abstract

The integration of CRISPR/Cas9 genome editing and nanotechnology is transforming precision medicine through the targeted, efficient, and safe delivery of gene-editing agents. With its great promise in the treatment of genetic disorders, the clinical application of CRISPR/Cas9 is hampered by delivery issues such as degradation, immunogenicity, and off-target effects. This chapter discusses the evolution and use of nano-delivery systems like lipid nanoparticles, polymeric carriers, dendrimers, gold nanoparticles, and exosomes to deliver CRISPR/Cas9 elements across biological barriers in a highly specific manner. Focus is given to nanoformulation strategies that maximize cellular uptake, endosomal escape, and nuclear localization with minimal systemic toxicity. Case studies of preclinical and clinical progress in nano-delivered CRISPR therapies for cancer, genetic diseases, and viral diseases are also presented. The chapter is wrapped up with perspectives on regulatory affairs and future directions on combining nanocarriers with genome editing for personalized medicine.

Related Content

Kazi Asraf Ali, Rideb Chakraborty, Naureen Afrose, Chowdhury Mobaswar Hossain, Amit Kotal, Sourav Samanta. © 2026. 34 pages.
V. N. Pallavi, Savitha Chowdareddy, Bhumika Iranna Byalahunasishetter, Ramya Raghavan. © 2026. 38 pages.
M. Suriya, V. Aarthi, S. S. Meenambiga, P. Prakash, P. Vivek. © 2026. 34 pages.
Kumar Ebenezar Kesavarao, Manoj Mani, Mokesh Kadhirvel, Balaji Esakkimuthu, Akilandeswari Govindraj, Jerline Babu Maria, Velayuthaprabhu Shanmugam, Vijaya Anand Arumugam. © 2026. 40 pages.
Ajay Sharma, Pratibha Singh. © 2026. 28 pages.
Arthi Gunasekaran, Muthupandi Vanaraj, Maria Sneha Philip Kumar, Abidharini Jothi Dheivasikamani, Arthi Boro, Antony Prabhu Jeyabal Philomenathan, Alwin Robert Asirvatham, Vijaya Anand Arumugam. © 2026. 34 pages.
Saloua Mabsor-Zgandaoui, Khawla Rachmoune, Soumia Ed-Day. © 2026. 30 pages.
Body Bottom